OKYO Pharma OKYO
NASDAQ OKYO
$1.42 -0.12 (-7.79%)
As of: Oct 22, 2026 · 11:05 AM EDT

OKYO Pharma (OKYO) Assets (2021 - 2026)

Updated

OKYO Pharma (OKYO) recorded Assets of $20.98 million in the quarter ended Mar 31, 2026, up 470.4% from $3.68 million a year earlier.

Analysis

OKYO Pharma (OKYO) Assets (2021 - 2026) Analysis & Trends

Starting with the quarter ended Mar 31, 2021, OKYO Pharma's Assets history includes 7 quarters.

  • Annual Assets has a five-year compound annual growth rate of 24.2% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Assets came in at $3.68 million in the year ended Mar 31, 2025 (+138.6%), $1.54 million in the year ended Mar 31, 2024 (-70.4%), $5.2 million in the year ended Mar 31, 2023 (+21.0%) and $4.3 million in the year ended Mar 31, 2022 (-39.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,172.56 Bn 1,141.15 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 637.42 Bn 555.95 Bn 17.26 Bn 201.06 Bn
3 AbbVie 504.13 Bn 477.24 Bn 12.70 Bn 135.12 Bn
4 Merck 377.81 Bn 332.19 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 304.36 Bn 268.35 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 267.51 Bn 241.20 Bn 12.86 Bn 115.83 Bn
7 Amgen 242.18 Bn 197.58 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.29 Bn 168.48 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.82 Bn 119.47 Bn 10.94 Bn 201.13 Bn
10 OKYO Pharma 955.33 Mn 928.55 Mn - 20.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 20.98 Mn
Sep 30, 2025 4.64 Mn
Mar 31, 2025 3.68 Mn
Sep 30, 2024 2.83 Mn
Mar 31, 2024 1.54 Mn
Sep 30, 2023 2.38 Mn
Mar 31, 2023 5.20 Mn
Mar 31, 2022 4.30 Mn
Mar 31, 2021 7.09 Mn
API Access

OKYO Pharma Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=OKYO&period=max&api_key=YOUR_API_KEY